Clinical Trials Logo
  1. Home
  2. Acute Coronary Syndrome (ACS)
  3. NCT01992484

Platelet Function in Patients With an Acute Coronary Syndrome — ATLANTIS-ACS  

Acute Coronary Syndrome (ACS) Clinical Trial

Official title:
Association Between the Antiplatelet Drug Efficacy/Safety and Platelet Function in Patients Treated With Novel Platelet Inhibitors Due to an Acute Coronary Syndrome

Clinical Trial Summary

The aims of the study are to:

- explore whether platelet reactivity in patients treated wih novel platelet inhibitors is associated with clinical outcome

- investigate whether a therapeutic window exist for novel platelet inhibitors

- investigate the incidence of adverse events under treatment with novel platelet inhibitors in the real life clinical scenario

- investigate the association between genetic polymorphisms, inflammation, platelet reactivity and clinical outcome

- investigate synergistic effects between aspirin and novel platelet inhibitors

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01992484
Study type Observational
Source Medical University of Vienna
Contact Jolanta M Siller-Matula, PD MD PhD
Phone 0043 1 404004614
Email jolanta.siller-matula@meduniwien.ac.at
Status Recruiting
Phase N/A
Start date August 2012
View Details
See also
  Status Clinical Trial Phase
Terminated NCT00385138 - Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition. Phase 3
Completed NCT01944800 - Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Phase 4
Completed NCT02286544 - Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers Phase 1
Completed NCT02290080 - Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers Phase 3
Completed NCT01405287 - Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT Phase 2
Completed NCT00767507 - Maintenance of Platelet Inhibition With Cangrelor Phase 2
Completed NCT03672097 - Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI) Phase 4
Completed NCT00399880 - Improving Medication Adherence Through Graphically Enhanced Interventions in Acute Coronary Syndromes N/A
Completed NCT02430493 - Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients N/A
Completed NCT01994577 - Optimum Troponin Cutoffs for ACS in the ED
Completed NCT00313300 - Safety Study of Apixaban in Recent Acute Coronary Syndrome Phase 2
Completed NCT02244710 - EndoTic - Endothelium and Ticagrelor N/A
Active, not recruiting NCT04090281 - Implementing Precision Medicine Approaches to Guide Anti-platelet Selection Phase 4
Active, not recruiting NCT03581578 - VITROS Immunodiagnostic Products hs Troponin I
Recruiting NCT04116931 - OPTImal Management of Antithrombotic Agents: OPTIMA-5 Phase 4
Completed NCT02171065 - PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial. N/A
Completed NCT00855257 - Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Acute Coronary Syndrome Phase 3
Completed NCT02733341 - The Effect of IV Cangrelor and Oral Ticagrelor Study Phase 4
Completed NCT02184884 - Effect of Perioperative Clopidogrel Responsiveness on Ischemic Outcome in Patients With Acute Coronary Syndrome Undergoing Off-pump Coronary Artery Bypass Surgery
Completed NCT00932100 - A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome Phase 2